Research Article

Comparison of HER2-Targeted Antibodies for Fluorescence-Guided Surgery in Breast Cancer

Figure 4

In vivo imaging of fluorescently-labeled trastuzumab and pertuzumab in mouse xenografts. Representative NIRF images at 48 h p.i. in BT474 (a) and MCF7 (b) xenografts show higher uptake in HER2-overexpressing tumors. Ex vivo images from corresponding BT474 (c) and MCF7 (d) mice confirm tumor uptake and show minimal signal in normal tissues. Quantification of tissue fluorescence and TBRs for BT474 (e, g) and MCF7 (f, h) mice. Data are presented as the . , , , and . FAU: fluorescent arbitrary units; TBR: tumor to background ratio. Arrow indicates the tumor.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)